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Abstract 
Air and moisture stable coordination compounds of late first row transition metal ions, viz., 
Co(II), Ni(II), Cu(II) and Zn(II) with a newly designed ligand, (E)-2-amino-N'-(1-(2-hydroxy-6-
methyl-4-oxo-4H-pyran-3-yl)ethylidene)benzohydrazide (H2L) were prepared and extensively 
characterized using various spectro-analytical techniques. The ligand acts both in mono as well 
as doubly deprotonated manner. The ligand to metal stoichiometry was found to be 1:2 in case of 
complexes using chloride salts, whereas 1:1 in caseof copper (II) complex using its acetate salt. 
The molecular structures of H2L, nickel and copper complexes were unambiguously determined 
by single-crystal X-ray diffraction studies reveal that H2L exists in a zwitterionic form while 
copper complex has copper centre in a distorted square planar environment. On the other hand, 
cobalt, nickel and zinc complexes display distorted octahedral coordination around the metal ion. 
In case of [Ni(HL)2].H2O, intramolecular C-H···π stacking interaction were observed between 
the centroid of five membered chelate ring and phenyl proton C(5)-H(5) and intermolecular C-















and phenyl protons. The [Cu(L)DMF] complex is stabilized by intramolecular hydrogen bonding 
N(1)H···N(2) and by intermolecular hydrogen bonding N(1)H···O(4). Intermolecular 
interactions were investigated by Hirshfeld surfaces. Further, H2L and its metal complexes were 
screened for their n vivo and in vitro anti-inflammatory activities. The activity of the ligand has 
enhanced on coordination with transition metals. The tested compounds have shown excellent 




• Transition metal complexes 
• Single crystal X-ray diffraction study 
• Mono-deprotonated and Doubly deprotonated 
• Hirshfeld surface analysis 
• Anti-inflammatory activity 
1. Introduction  
The coordination chemistry of N-acyl hydrazone (NAH) ligands has captivated 
considerable assiduity in past few decades, due to their chelating capability, structural flexibility, 
variable bonding modes towards transition metal ions a d a wide range of biological applications 
[1-4]. NAH has also been used as the bedrock for designing new analgesic and anti-
inflammatory compounds, because the NAH subunit is a primal pharmacophore for binding to 
and inhibiting cyclooxygenases (COXs) [5]. A number of transition metal complexes of NAH 
have been reported to exhibit DNA interactions, as well as antimicrobial and antitumor 















presence of –CONHN=CH– moiety. On coordination, theactivity of hydrazone increases. 
Moreover, coordination suppresses the polarity of the metal ion because of the partial sharing of 
its positive charge with the donor atom inside the chelate ring system, formed during 
coordination. This process consecutively increases th  lipophilic nature of the central metal 
atom/ion, which in turn favours its pervasion more efficiently through the lipid layers of the 
microorganism [8b,c]. 
Further, transition metal complexes of NAH have also shown high catalytic activities in 
various chemical reactions, to name a few, epoxidation of olefins [9-10], polymerization of 
ethylene [11], and transamidation of carboxamides with amines [12], etc. Aggoun et al., 
described the electrocatalytic behaviour of the copper complex of hydrazone ligand prepared by 
condensation of dehydroacetic acid on 1,2-diaminopropane towards electro-reduction of alkyl 
and aryl halides [13]. 
Dehydroacetic acid (DHA), a pyranone derivative is a herculean material which is 
involved in the synthesis of many heterocyclic compunds. It is prepared by the base-catalyzed 
(tert-amines; imidazole; 1,4-diazabicyclo[2.2.2]octane (DABCO); pyridine) dimerization of 
diketene. These compounds have occupied a dominating position in coordination chemistry that 
explores therapeutic and pharmacological activities [14,15]. Studies on metal chelates with 
Schiff base of dehydroacetic acid have been reported du  to their excellent chelating capacity in 
modern coordination chemistry. Recently, Edward et.al., reported the design and synthesis of a 
novel class of diaryl heterocyclic with a central six-membered lactone (pyran-2-one) ring which 
exhibited good in vitro COX-2 inhibitory potency and selectivity [16a-h]. Cobalt, nickel, copper 
and zinc being bio-essential elements, it is conceived that their complexes may find more 















Considering the above-mentioned facts and in continua on of our ongoing research on 
the study of pharmacological properties of transition metal complexes, the present work was 
undertaken as an attempt to explore the structural rel tionship of DHA derived hydrazone with 
late first row transition metals. Here we report the synthesis and characterization of the DHA 
derived ligand, its transition metal complexes. A preliminary screening for in vivo and in vitro 
anti-inflammatory activity of these new compounds was also studied. 
2. Experimental  
2.1. General procedures  
All the reagents used in this study were purchased from Sigma Aldrich and used as 
rendered. The synthesis of precursor, o-aminobenzoylhydrazide the precursor was synthesized 
according to the procedure reported earlier [18, 19]. Infrared spectra of the ligand and its metal 
complexes were recorded in the region 4000–400 cm-1 on a Nicolet 170 SX FT-IR spectrometer 
(KBr disc matrix). The 1H NMR and 13C NMR spectra were recorded on a Bruker AV400 II 
spectrometer at 400 MHz in DMSO-d6/CDCl3 at room temperature using TMS as an internal 
reference. All the compounds were analyzed for carbon, hydrogen and nitrogen using a Thermo 
quest elemental analyzer and metal complexes were analyzed for their metal content by standard 
methods [20]. The UV–Vis spectra of all the compounds in DMF were recorded on a Varian 
Cary 50 Bio UV–Vis spectrophotometer. Thermograms of the metal complexes were recorded in 
nitrogen atmosphere on a SDT Q600 Analyzer, keeping the final temperature at 1000°C with a 
heating rate of 10°C/min heating rate. The molar conductivity measurements of 1 mM solutions 
in DMF were carried out on equiptronics EQ-665 conductivity bridge. EPR spectra were 
recorded both at room temperature (300K) and liquid nitrogen temperature (77K) on a Varian E-















frequency of 9.65 GHz under the magnetic strength of 3000 G. The EI mass spectrum of the 
ligand was obtained with a Shimadzu GCMS-QP2010S spectrometer. The ESI mass spectral data 
for all the complexes were obtained from Agilent Technologies India Pvt. Ltd. The X-ray 
diffraction data of nickel complex were collected at 293 K on a Bruker SMART APEX2 CCD 
area-detector diffractometer using a graphite monochromater Mo-K	(λ = 0.71073 Å) radiation 
source. The frames were integrated with the Bruker SAINT Software package using a narrow-
frame algorithm. In the absence of anomalous scattering, Friedel pairs were merged. The H 
atoms were all located in a difference map, but those attached to carbon atoms were repositioned 
geometrically. The H atoms were initially refined with soft restraints on the bond lengths and 
angles to regularize their geometry, after which the positions were refined with riding constraints 
[21]. All non-hydrogen atoms were refined anisotropically. Structure solution and refinement 
were performed using Crystals [22]. Molecular graphics were generated using Cameron [23]; 
structure figures were generated with ORTEP-III [24a]. The X-ray diffraction data of ligand and 
copper complex were collected on an Oxford Diffraction (Agilent Technologies), SuperNova X-
ray diffractometer equipped with an Oxford Cryosystems Cobra Low temperature device using 
Cu-K radiation (λ	= 1.54184 & 1.54178 Å ) from a Super Nova Cu X-ray micro source and 
focusing mirror optics. The structures were solved by direct methods and refined against F2 by 
fullmatrix least-squares using the program SHELXTL [24b]. 
2.2. Synthesis of (E)-2-amino-N'-(1-(2-hydroxy-6-methyl-4-oxo-4H-pyran-3-yl)ethylidene)benzo 
hydrazide (H2L) 
A methanolic solution of o-aminobenzoylhydrazide (2 g; 0.01 mol) was added dropwise 
to a solution of 2-acetyl-5-hydroxy-3-oxo-4-hexenoic acid δ-lactone (2.23 g; 0.01 mol) in 















shaker. The progress of the reaction was monitored using TLC. The precipitate formed was 
filtered off, washed with methanol and then dried in vacuo. Pale yellow crystals obtained from 
slow evaporation of its methanolic solution were suitable for single crystal X-ray diffraction 
(SC-XRD) analysis. Schematic representation for the synthesis of ligand is given in (Scheme 1).  
Yield: 87 %; m.p.: 193°C; Color: Pale yellow .Anal. Calcd for C15H15N3O4 (%): C, 59.79; H, 
5.02; N, 13.95. Found (%): C, 59.82; H, 4.98; N, 13.92. IR (cm-1):  = 3323 (m, NH2,sym.); 
3357 (m, NH2 asym.);  3447 (m, N-H); 1675 (s, pyranone C=O); 1645 (s, amide C=O); 1619 (m, 
C=N).1H NMR (DMSO-d6, 400 MHz) (ppm) :15.90 (s, 1H, O3H), 8.065 (s, 2H, N1H2), 5.838 
(s, 1H, C11H), 6.772 (d, J=8.4Hz, 1H, C4H). 13C NMR (DMSO-d6, 100 MHz)	(ppm): 162.9 
(azomethine C8=N), 170.8 (C7=O), 106.2 (C11H), 16.5 (C14H3), 19.2 (C15H3). max (nm): 270 
π → π*, 351       n → π*. 
2.3. Synthesis of metal complexes 
Methanolic solutions of NiCl2.6H2O (0.19 g, 0.8 mmol), CuCl2.2H2O (0.14 g, 0.8 mmol) 
and Cu(CH3COO)2.H2O (0.16 g, 1.6 mmol) were added dropwise to the methanolic solution of 
H2L (0.50 g, 1.6 mmol) and stirred for 2 h on mechanic l shaker. Co(II) and Zn(II) complexes 
were obtained by refluxing methanolic solution of CoCl2.6H2O (0.19 g, 0.8 mmol) and 
anhydrous ZnCl2 (0.11 g, 0.8 mmol) with methanolic solution of H2L for 3 h on water bath. The 
products obtained were filtered off, washed with hot methanol and dried in vacuo. Slow 
evaporation of methanolic solution of Ni(II) complex and  DMF solution of Cu (II) complex 
which was obtained by using Cu(CH3COO)2.H2O salt yielded dark green color single crystals at 
room temperature suitable for XRD study. Attempts to grow single crystals of the remaining 
















2.3.1. [Co(HL)2]  
Yield: 52.2 %, Color: purple. Anal. Calcd for C30H28CoN6O8 (%): C, 54.63; H, 4.28; N, 12.74; 
Co, 8.94. Found (%): C, 54.68; H,4.25; N, 12.78; Co, 8.90. IR (cm-1):  = 1674 (s, pyranone 
C=O); 1620 (s, amide C=O); 1571 (m, C=N). max (nm): 273 π → π*, 373 n → π*, 610 & 674 
(d–d transitions). Molar conductivity : 3.06 ohm-1 cm2 mol-1 
2.3.2. [Ni(HL)2].H2O  
Yield: 53.6 %, Color: green. Anal. Calcd for C30H30N6NiO9 (%): C, 53.20; H, 4.46; N, 12.41; Ni, 
8.67. Found (%): C, 53.16; H, 4.49; N, 12.39; Ni, 8.69. IR (cm-1): = 1670 (s, pyranone C=O); 
1615 (s, amide C=O); 1574 (m, C=N). max(nm): 274 π → π*, 395 n → π*, 554 & 940 (d–d 
transitions). Molar conductivity: 2.54 ohm-1 cm2 mol-1 
2.3.3. [Cu(HL)2] 
Yield: 52.8 %, Color: dark green. Anal. Calcd for C30H28CuN6O8 (%): C, 54.26; H, 4.25; N, 
12.65; Cu, 9.57. Found(%): C, 54.23; H,4.21; N, 12.62; Co, 9.53. IR (cm-1):  = 1677 (s, 
pyranone C=O); 1637 (s, amide C=O); 1599 (m, C=N). max(nm): 275 π → π*, 386 n → π*, 714 
(d–d transitions). Molar conductivity: 1.98 ohm-1 cm2 mol-1 
2.3.4. [Zn(HL)2]  
Yield: 44.8 %, Color: Yellow. Anal. Calcd for C30H28ZnN6O8 (%): C, 51.54; H, 4.97 ; N, 13.03; 
Zn, 3.38. Found (%): C, 51.59; H, 4.95 ; N, 13.07; Zn, 3.41. IR (cm-1):  = 1682 (s, pyranone 
C=O); 1648 (m, amide C=O); 1590 (m, C=N). 1H NMR (DMSO-d6, 400 MHz) (ppm) : 6.935 
(s, 2H, N1H2), 5.737 (s, 1H, C11H), 6.633 (d, J=8.4Hz, 1H, C4H). 
13C NMR (DMSO-d6, 100 
MHz)	(ppm): 160.1(azomethine C8=N), 169.6 (C7=O), 107.2 (C11H), 18.9 (C14H3), 19.4 
(C15H3).max(nm): 276 π → π*, 384 n → π*. Molar conductivity: 3.19 ohm
















Yield: 63.4 %, Color: green. Anal. Calcd for C15H15CuN3O5 (%): C, 47.31; H, 3.97; N, 11.03; 
Cu, 16.69. Found(%):C, 47.28; H, 4.00; N, 11.09; Cu, 16.72. IR (cm-1):  = 1670 (s, pyranone 
C=O); 1608 (s, amide C=O); 1575 (m, C=N); 1357 (m, C-O). max(nm): 273 π → π*, 390 n → 
π*, 630 & 635 (d–d transitions). Molar conductivity: 1.98 ohm-1 cm2 mol-1 
 2.4. Pharmacology 
Ligand and its metal complexes were evaluated for in vivo anti-inflammatory activity by 
carrageenan-induced rat paw edema model [25,26] and for in vitro anti-inflammatory activity by 
protein denaturation method [27]. 
2.4.1. In vivo anti-inflammatory activity: Carrageenan-induced rat paw edema model 
In vivo anti-inflammatory activity was measured as described y Winter et al. [25]. One 
hour after the administration of the test compounds, the paw edema was induced by injecting 1% 
carrageenan lambda (a pro-inflammatory agent; prepared in 0.9% NaCl) hypodermically in the 
sub-plantar region of right hind paw. The test compunds were suspended in 0.5% sodium 
carboxy methyl cellulose (Na–CMC) and administered at dose of 5 and 10 mg/kg per body 
weight and declofenac, an anti-inflammatory drug in use was administered orally at a dose of 10 
mg/kg, p.o. as the standard. The control group receiv d 0.5% Na–CMC in distilled water. The 
paw volume was measured at different intervals of time (0.5, 1, 3 and 5 h) using a digital 
plethysmometer (UGO Basile, Italy), before and after injection of 1% carrageenan lambda. 
Results were expressed in terms of edema volume as Me n	± SEM and mean percent inhibition 
according to the following equation, 
Edema Volume = Vt - Vc 
where, Vt – Paw volume in mL, at time t, after carrageenan administration. 















Percent inhibition = Ec - Et / Ec 
where, Ec – Edema volume of rat of control group, at time t 
Et – Edema volume of rat paw, at time t 
2.4.2. In vitro anti-inflammatory activity: Egg albumin denaturation method  
A mixture contained 0.2 mL of egg albumin (from fresh hen's egg), 2.8 mL of phosphate 
buffered saline (PBS, pH 6.4) and 2 mL of various concentrations of ligand and its metal 
complexes so that final concentrations become 31.25, 6 .5, 125, 250, 500,1000 µg/mL and 
similar volume of double-distilled water served as control. Later the mixtures were incubated at 
(37 ± 2) °C in an incubator (Bio-technics, India) for about 15 min and then heated at 70 °C for 5 
min. After cooling, their absorbance was measured at 660 nm (UV-1800 Spectrophotometer, 
SHIMADZU) by using vehicle as blank. Aceclofenac sodium was used as reference drug and 
treated similarly for determination of absorbance. The percentage inhibition of protein 
denaturation was calculated by using the following equation, 
% Inhibition = 100 ×	(Abs of control - Abs of sample) / Abs of control. 
 2.5. Hirshfeld surface analysis 
Hirshfeld surfaces (HSs) and 2D fingerprint plots (FPs) were generated using Crystal 
Explorer 3.1 [28] based on results of SC-XRD studies. The function dnorm is a ratio encompassing 
the distances of any surface point to the nearest interior (di) and exterior (de) atom and the van 
der Waals radii of the atoms [29 a,b]. The negative value of dnorm indicates the sum of di and de is 
shorter than the sum of the relevant van der Waals radii, which is measured to be a closest 
contact and is visualized as red colour in HSs. Thew ite colour represents intermolecular 
distances close to van der Waals contacts with dnorm equal to zero, whereas contacts longer than 















versus de is a 2D fingerprint plot which recognizes the existence of different types of 
intermolecular interactions.  
3. Results and discussion 
3.1. Single crystal X-ray diffraction and Hirshfeld surface analyses of H2L, [Ni(HL)2].H2O and 
[Cu(L)DMF] 
Summaries of the crystallographic data, selected bond lengths and bond angles of H2L, 
[Ni(HL) 2].H2O and [Cu(L)DMF] are given in Tables S1 and 1, respectively. ORTEP 
representations (asymmetric unit) of the same showing 50% displacement ellipsoids are shown in 
Figures 1-3. 
The single-crystal X-ray structure of H2L was determined at 100 K and is shown to be 
monoclinic with space group P21/n. Asymmetric unit of H2L consists of 3 molecules namely A, 
B and C with a small trace of crystal held water molecule, (O1W) refines to just under 5% per 3 
molecules of H2L. These three molecules A, B and C differ marginally from one another in their 
bond distances and bond angles. Such crystallographically independent and chemically similar 
molecules are known as bond stretch isomers [30 a,b]. All the three conformers of the ligand is 
found to exist in zwitterionic form and formally a neutral species as evident by presence of acidic 
proton (H3AB,H3BB,H3CB) on N3A,N3B,N3C respectively, rather than O2A,O2B,O2C where 
there exists a single bond character for C11-O2 and double bond character for C8-N3 [30c]. 
Azomethine and ˃C=O (mean of O1-C7-N2-N3-C8) form a dihedral angle of  24.03° with the 
phenyl ring (mean of C1–C6)  and 17.09° with  DHA ring (mean C10-C11-C12-C13-O3-C15) 
respectively. Furthermore, the azomethine ˃C=N bond distance (1.309(16) Å) agrees well with 
the values for double bond character confirming the formation of imine bond. The torsion angles 















and -4.19(18) to 2.10(18)° by C8–C10–C11–O2  indicate that N3,O1 ; N3,C11 and C8,O2 are cis 
to each other respectively, while the torsion angle -159.44(12) to 158.01(11)° exhibited by C7–
N2–N3–C8 indicates that C7 and C8 are  t ans to each other. The structure of H2L is stabilized 
by intramolecular N3-H···O2 (2.481(13) Å); N1-H···O1(2.712(15) Å) and intermolecular N1-
H···O2 (2.909(14) Å); N2-H···O4 (2.916(13) Å) hydrogen bonding (Table 2).  
The crystal structure of [Ni(HL)2].H2O contains 0.5 molecule in the asymmetric unit and 
structure dimerises across the inversion center. Hence, results in a pair of tridentate ligands 
coordinated in mer fashion, through an amide carbonyl oxygen, azomethin  nitrogen and oxygen 
of -OH (pyranone ring) via deprotonation. According to International Tables for 
Crystallography, [Ni(HL)2].H2O having space group P31, the nickel ion occupies a general 
position 3a. The bonds Ni–O1(2.082(2) Å), Ni–N3 (2.022(2) Å) and Ni–O2 (1.987(2) Å) 
forming one five-membered CN2ONi and other six-membered C3NONi chelate rings with bite 
angles of 78.75° and 88.08°, respectively, suggest distortion from an ideal octahedral geometry 
[31]. The bond lengths in [Ni(HL)2].H2O for: C7–O1 = 1.240(4), N3–C8= 1.289(4) and C11–
O2= 1.276(4) Å, which are longer or shorter than those of the corresponding distances in the free 
ligand H2L, C7–O1 = 1.231(15), N3–C8= 1.309(16) and C11–O2= 1.264(15) Å is due to the 
coordination of ligand to the central Ni(II) atom. The crystal is stabilized by intramolecular N1-
H···Ow (3.207(8) Å) and intermolecular N1-H···O4 (3.312(5) Å); N2-H···O4 (2.978(4) Å); Ow-
H···O2 (2.853(4) Å) hydrogen bonding (Table 2). In addition, the molecule is stabilized by 
intramolecular C-H···π stacking interactions between the centroid of fivem mbered chelate ring 
and phenyl proton C5-H5, with the contact distance of 3.400 Å and two intermolecular C-H···π 
stacking interactions, one between the centroid of phenyl ring and proton of DHA ring C12-















distances of 3.685 and 3.228 Å respectively (Fig. S1). The C-H···π interactions are important 
noncovalent intermolecular forces similar to hydrogen bonding.  
The single-crystal X-ray structure of [Cu(L)DMF] was determined at 100 K and is shown 
to be Triclinic with space group P-1. Asymmetric unit of [Cu(L)DMF] consists of one molecule. 
The crystal structure of [Cu(L)DMF] contains a tridentate ligand coordinated through an amide 
carbonyl oxygen via deprotonation after enolisation, azomethine nitrogen and oxygen of -OH 
(pyranone ring) via deprotonation and also contains a molecule of coordinated DMF. The 
structure forms a dimer across the inversion centre via a long, (2.685Å), Cu-N bond. The ONO 
donor sites of the tridentate ligand coordinate to  the Cu(II) centre forming one five-membered 
CN2OCu and other six-membered C3NOCu chelate rings with bite angles of 82.98° and 92.10°, 
respectively, represents distortion from an ideal square planar geometry. The average bond 
lengths in the complex are: C7–O1 = 1.299(19), N3–C8= 1.308(2) and C11–O2= 1.281(19) Å, 
which are longer or shorter than those of the corresponding distances in the ligand, suggesting 
considerable delocalization of the charge on the chelate rings [32a]. [Cu(L)DMF] is stabilized  
by intramolecular hydrogen bonding N1-H···N2 (2.691(19) Å) and also by intermolecular 
hydrogen bonding N1-H···O4 (2.997(18) Å) (Table 2). In addition, the molecule is stabilized by 
three intermolecular C-H···π stacking interactions acting between the centroid of chelate ring 
and phenyl proton C2-H2, the centroid of DHA ring and phenyl protons C2-H2 & C3-H3, with 
the  contact distances of 3.549, 3.758, 3.577 Å respectively (Fig. S2). The π ···π interactions can 
play an important role in packing. In this structure the π ···π interaction is an offset stacking, i.e. 
the rings (DHA and phenyl) are parallel slipped. The ring normal and the vector between the ring 















Hirshfeld surface analysis is a technique which reproduces the results of X-ray crystal 
structure analysis and helps to elucidate all the int rmolecular interactions in a novel visual 
manner [33]. This method uses visual recognition of properties of atom contacts through 
mapping of a range of functions (dnorm, shape index, curvedness, etc.) onto this surface [34]. The 
increasing popularity of this tool comes from the fact that it allows for recognition of less 
directional contacts, for instance, H···H dispersion f rces. Another essential advantage is that all 
(di, de) contacts created by a molecule of interest can be expressed in the form of a two-
dimensional (2D) plot, known as the 2D fingerprint plot. The de and di are defined, respectively, 
as the distance from the Hirshfeld surface to the nearest atom in the molecule itself and the 
distance from the surface to the nearest nucleus outwards from the surface. The shape of this 
plot, which is unique for each molecule, is determined by dominating intermolecular contacts 
[35]. The Hirshfeld surface mapped with a dnorm function for the H2L, [Ni(HL) 2].H2O and 
[Cu(L)(DMF)] (Fig. 4a-4c) clearly shows the red spots derived from hydrogen bonding 
interactions. The plots of 2D fingerprint for the H2L,  [Ni(HL) 2].H2O and [Cu(L)(DMF)] (Fig. 
4a-4c) shows the most significant H·· ·H interactions with contribution of 37.9%, 41.8% and 
47.0% respectively, other C···H interaction characterized by winglike peripheral spikes (21.1%, 
24.2% and 15.4% respectively), N···H (4.6%, 4.7% and 2.8% respectively) and O···H 
characterized by longer and thinner spikes (26.3%, 26.7% and 20.9% respectively) (Fig. 4d). The 
non-directional H···H contacts are characterized by broader spikes in [Cu(L)(DMF)] and 
relatively sharper spikes in H2L, [Ni(HL) 2].H2O. And, the percentage contribution of H···H 
contact is also a measure of strength of the crystal lattice [36]. The measureables like volume 
(VH), area (SH), globularity (G) and asphericity (V) can also be calculated using HSs. The term, 















that the molecular surface is more structured, not a sphere. The asphericity [38a,b] is a measure 
of anisotropy which decreases in the ensuing order for the compounds: [Cu(L)(DMF)] > H2L > 
[Ni(HL) 2].H2O. 2D fingerprint plots of the H2L, [Ni(HL) 2].H2O and [Cu(L)(DMF)] of different 
intermolecular contacts are displayed in Figures 4d and S22. 
3.2. Spectral studies 
The IR spectrum of the ligand (H2L) showed two highest frequency bands of medium 
intensity at 3357 and 3323  cm-1 ascribed to asymmetric and symmetric modes of the 
(-NH2) 
group, respectively. These frequencies have appeared slightly at lower wave number compared 
to reported compound (2-aminobenzyolhydrazone of 1,3-dione) [39], probably due to the 
involvement of free amino group in intramolecular hydrogen bonding with the oxygen of C=O of 
hydrazide moiety as confirmed by crystallographic studies. The presence of symmetric and 
asymmetric bands in all the metal complexes due to –NH2 group indicate the non-involvement of 
this group in coordination to the metal centres. A medium intense band at 3447 cm-1 in the free 
ligand is ascribed to 
(–OH) (pyranone ring). A strong band at 1645 cm-1 in H2L is assigned to 
amide 
(C=O). This band shows a negative shift in all the complexes except [Cu(L)(H2O)] 
indicating its coordination to the metal ion. The absence of –OH (pyranone ring) stretching band 
in all the complexes, clearly indicates the involvement of pyranone oxygen in coordination with 
the metal ion via deprotonation [40]. The strong band t 1619 cm-1 due 
(C=N) in the ligand has 
shifted to lower wave number i.e. ~1599 cm-1 in the spectra of all the complexes indicating its 
coordination to the metal ion. The presence of strong band at 1675 cm-1 assigned to 
(C=O) of 
pyranone ring in ligand and all the complexes indicates its non-involvement in coordination. The 
above assignments suggest that the ligand has coordinate  through amide carbonyl oxygen, 















complexes except [Cu(L)(H2O)]. In case of [Cu(L)(H2O)], amide carbonyl stretching ν(C=O) is 
absent while new bands have been observed at 1608 and 1357 cm-1. These are ascribed to newly 
formed 
(C=N) and 
(C-O) groups respectively. This indicates the involvement of amide 
carbonyl oxygen in coordination via enolisation and deprotonation [41a]. Thus, the IR spectral 
data clearly reveals that the ligand acts as monobasic for all complexes except [Cu(L)(H2O)] 
where it behaves as doubly deprotonated, tridentate ligand. The IR spectra of H2L, [Cu(HL)2] 
and [Cu(L)(H2O)] (Fig. S4, S5 and S6) are provided as the supplementary material. 
A broad singlet at 15.76 ppm in the free ligand, ascribed to OH proton has disappeared in 
the 1H NMR spectrum of [Zn(HL)2], indicating the coordination of oxygen of –OH group 
(pyranone ring) via deprotonation to the metal ion. A broad singlet at 8.06 ppm is assigned to 
two protons of N1. This signal has shifted upfield by 1.13 ppm, revealing the breakdown of 
intramolecular hydrogen bonding upon complexation. The signals due to OH proton and two 
protons of N1 are D2O exchangeable (Fig. S8). A singlet appeared at 5.84 ppm in free ligand 
ascribed to C12-H corresponds to one proton. A doublet and triplet at 6.77 and 6.57 ppm in free 
ligand are assigned to C2-H and C4-H, respectively. The aromatic protons resonated as 
multiplets in the region 7.57-7.24 ppm in the spectrum of the free ligand have shifted slightly 
downfield in the spectrum of [Zn(HL)2]. The C9-H3 and C14-H3 protons observed as singlets at 
2.11 and 2.61 ppm in uncoordinated ligand have shifted to 2.06 and 2.49 ppm, respectively on 
complexation. The 1H NMR spectra of H2L (Fig. S7) and [Zn(HL)2]  (Fig. S9) are provided as 
the supplementary material. In the 13C NMR spectrum of the ligand, the signals at 166.7 and 94.7 
ppm correspond to C11 and C9, respectively, and have shifted to 164.4 and 98.0 ppm in the 13C
NMR spectrum of [Zn(HL)2]  indicating the coordination of oxygen of –OH group (pyranone 















C14 and C9, respectively. The azomethine carbon suffer  a downfield shift in the spectrum of 
[Zn(HL)2] indicating the involvement of azomethine nitrogen in coordination to the metal ion. 
Methyl carbon C14 also showed a downfield shift in [Z (HL)2], indicating the coordination of 
oxygen of –OH group (pyranone ring)  via deprotonation o the metal ion. The 13C NMR spectra 
of  H2L (Fig. S10) and [Zn(HL)2] are provided as the supplementary material (Fig. S11).
1H NMR 
and 13C NMR spectra of [Zn(HL)2]  suggests coordination of the ligand through oxygen of –OH 
group (pyranone ring) via deprotonation, azomethine nitrogen and amide carbonyl oxygen.  
The mass spectrum of the ligand (Fig. S12) has shown the molecular ion peak [M] + at 
m/z 301. The ESI mass spectra of [Co(HL)2], [Ni(HL) 2].H2O and [Zn(HL)2] complexes are given 
as supplementary material (Fig. S13, S14 and S15). ESI mass spectral studies of [Co(HL)2], 
[Ni(HL) 2].H2O, [Cu(HL)2], [Zn(HL)2]  and [Cu(L)(H2O)] show their molecular ion peaks 
[M+H] + at 659, 659, [M+K]+ at 700, [M+Na]+ at 689 and [M+H]+ at 380 respectively.  Apart 
from this, spectra also show some additional peaks, which are due to molecular cations of 
various fragments of the complexes. By comparing the analytical and spectral data of all the 
complexes relevant structures were assigned. 
The X-band EPR spectra of paramagnetic [Cu(HL)2] complex was measured in the solid 
state at room temperature and in solution state (DMF) at liquid nitrogen temperature i.e. 77 K. 
EPR spectra is recorded only for copper complexes, due to the magnetic interactions between the 
paramagnetic copper centers [41b]. EPR spectra of [Cu(HL)2] are shown in (Fig. S16 and S17). 
The EPR spectrum at 300 K show a broad absorption band, which is isotropic due to tumbling 
motion of molecule. The ‘giso’ value at 300 K is 2.06. The g∥ and g	values observed for the 
complex at 77K are 2.27 and 2.04, respectively. Thetrend observed, g∥ > g	> 2.02, for the 















electron residing in dx2-y2 orbital [42 a,b]. The g∥ value (2.27 < 2.3) indicates a larger percentage 
of covalency of metal-ligand bonding [43a]. In axial symmetry the g-values are related by the 
expression [43 b,c].  
G = g∥ − 2/g⊥	 − 2 
 where, G is a measure of the exchange interaction between copper centers in the 
polycrystalline solid. According to Hathway, if the values of the G are greater than the 4, the 
exchange interaction is negligible, whereas when the value of G is less than 4 considerable 
interaction is indicated in the solid complex [42, 43d]. In present investigation the axial 
symmetry parameter G being more than 4, rules out the exchange interaction between the copper 
centers. 
3.3. Electronic Spectral Studies 
The electronic spectra of the ligand, as well as complexes, were recorded in DMF 
solvent. The ligand exhibit two absorption bands in the UV–visible region around 270 and 351 
nm. The first intense band around 270 nm is assigned to a ligand π → π* transition. This band 
remains almost unchanged in the spectra of all the complexes. The second broad band around 
351 nm assigned to n→π* transition, has suffered bathochromic shift upon complexation [44a]. 
This is an indication of coordination of azomethine nitrogen to the metal ions. For [Co(HL)2], 
two spin-allowed transitions observed at 915 and 756 nm were assigned to 4T1g(F) → 
4T2g (ν) 
and 4T1g(F) → 
4A2g (ν) transitions indicating an octahedral geometry around Co(II) ion [44a,b]. 
The electronic spectrum of [Ni(HL)2].H2O displays d–d transitions around 554 and 940 nm, 
assignable to 3A2g(F) → 
3T1g(F) (ν) and 
3A2g(F) → 
3T2g(F) (ν) transitions, respectively, 















[Cu(HL)2], assigned to the 
2Eg → 2T2g transition reveals an octahedral geometry [46a,b]. Broad 
band in the electronic spectrum of [Cu(L)(H2O)] with peak maxima at 620 nm was assigned to 
the combination of 2B1g →2A1g and 2B1g → 2Eg transitions suggest a square-planar configuration 
around the Cu(II) ion [47,48]. The π → π*, n→π* and d–d transition bands exhibited by the 
ligand and its metal complexes are shown in Figures S18 and S19.  
3.4. Thermal Studies 
Thermal studies (TG and DT analaysis) of all the complexes have been undertaken to 
know the presence/absence of coordinated/lattice held solvent/water molecules, to confirm their 
composition and to understand the thermal stability. The thermogram of [Ni(HL)2].H2O showed 
a weight loss of 2.70% (Calc. 2.66%) between the temperature range 50 and 100°C indicating the 
presence of one lattice held water molecule. This is clearly evidenced in DTA curve in the form 
of an exothermic peak at 75°C. Weight loss of 88.82% (Calc. 88.75%) around 200–527°C 
corresponds to the loss of two ligand molecules. This process is further supported by two 
exothermic peaks in DTA curve at 299 and 440°C. Theplateau obtained after heating above 
450°C corresponds to the formation of stable nickel oxide and the metal content (8.60%) 
calculated from this residue tallies with the metal analysis (8.57%). 
[Co(HL)2] has remained thermally stable up to a temperature of 200°C, showing the 
absence of any lattice held molecules. The weight loss of about 91.70% (Calc. 91.06%) in the 
range of 200–620°C is due to the loss of a two ligand molecules. This is clearly evidenced in 
DTA curve in the form of two exothermic peaks at 276 and 590°C. The plateau obtained after 
heating above 600°C corresponds to the formation of stable cobalt oxide.  
The thermogram of [Cu(L)(H2O)] showing a weight loss of  4.80 % (Calc. 4.73 %)















molecule. Weight loss of 78.76% (Calc. 78.68%) around 250–540°C correspond to the loss of a 
ligand molecule. The plateau obtained after heating above 470°C corresponds to the formation of 
stable copper oxide. In case of [Cu(HL)2] and [Zn(HL)2] complexes, no weight loss was 
observed up to the temperature 260°C and indicates the absence of any lattice held/coordinated 
solvent molecule. The weight loss of 85.27 and 90.03% (Calc. 85.22% and 90.22%) around 265–
650°C correspond to the loss of two ligand molecule. Weight of the residue obtained after 
heating the complex above 650°C corresponds to the formation of stable metal oxides.  
Thus, thermal studies support the suggested composition for the complexes. As 
representatives, thermograms of [Ni(HL)2].H2O and [Co(HL)2] are given in Figures S20 and S21 
respectively.  
3.5. Anti-inflammatory activity 
In the present investigation, the control group showed a significant increase of edema in the right 
hind paw of the animals in the plantar region. This is due to the release of inflammatory 
mediators such as histamine, serotonin, kinins, and prostaglandins (PGs). The edema 
development after carrageenan injection has been describ d as a biphasic event in which various 
mediators operate in sequence to produce this inflamm tory response. The initial phase of edema 
(0-1 h), which is not inhibited by non-steroidal anti-i flammatory drugs, has been attributed to 
the release of histamine, 5-hydroxytryptamine (5-HT) and bradykinin. In contrast, the second 
accelerating phase of swelling (1-6 h), has been correlated with the elevated production of 
prostaglandins [49], and more recently has been attributed to the induction of inducible cyclo-
oxygenase (COX-2) in the hind paw. Local neutrophil inf tration and activation also contribute 
to this inflammatory response by producing, among other mediators, oxygen-derived free 















most fundamental actions of acute inflammation and is an essential parameter to be considered 
when evaluating compounds with potential anti-inflammatory activities [50a].  
The coordination of bioactive molecules to metal ions is a promising approach to improve the 
therapeutic potency and/or to decrease the toxicity of drug molecules. The resulting metal complexes 
possess greater lipophilicity profiles compared to the free ligands, allowing them to more easily pass 
through cell membranes to exert their biological effects [8b,c].  
3.5.1. In vivo anti-inflammatory activity 
The anti-inflammatory activity of the newly synthesized compounds were evaluated by applying 
the carrageenan-induced paw edema bioassay in rats using diclofenac as reference drug [50b-d]. 
In the present investigation, the ligand and its metal complexes exhibited a dose-dependent 
response (Table 3). The ligand, H2L showed a consistent and significant decrease in paw edema 
at 0.5, 1, 3 and 5 h after drug administration, while complexes at higher dose gave a good 
response up to the fifth hour but at a lower dose, th  significant response decreased as time 
advanced. Further, the copper complexes ([Cu(HL)2] and [Cu(L)(H2O)]) showed significant 
inhibition of paw edema at a lower concentration of 5 mg/kg. The percentage inhibition (22-
82%) shown by [Cu(HL)2] over the time period of 0.5–1 h was significant ad comparable with 
the standard compound, viz. Diclofenac (90-98%) (Fig. 5a-5b).In comparison with H2L, all the 
complexes showed excellent effect at 0.5 and 1 h, [Co(HL)2], [Zn(HL)2]  and [Cu(L)(H2O)] 
retained their activity up to fifth hour, while [Ni(HL)2].H2O and [Cu(HL)2] showed a gradual 
decrease in activity. The enhanced anti-inflammatory activity of the complexes compared to the 
free ligand may be explained on the basis of enhanced pervasion through cellular membrane on 
complexation by Tweedy’s Chelation theory and Overtone’s concept [51a]. According to 















passage of only the lipid-soluble materials in which liposolubility as an important factor, which 
controls the biological activity. On chelation, the polarity of the metal ion will be reduced due to 
the overlap of the ligand orbital and partial sharing of the positive charge of the metal ion with 
donor groups [51b]. It is also expected that the more extensive heteroaromatic ring like DHA and 
the presence of lipophilic group C=N would bestow greater lipophilicity on complexes and 
enable it to penetrate the cell wall and promote adverse intracellular interactions [51c]. Hence, 
the enhanced activity of the complexes can be related to reduced overall polarity of the molecule, 
which increases the lipophilic nature of the complex, favoring the efficient permeation through 
lipid layer.  
3.5.2. In vitro anti-inflammatory activity 
In vitro pharmacological evaluation of the title compounds was carried out to evaluate 
their anti-inflammatory activity. All the synthesized compounds were subjected to anti-
inflammatory effect against denaturation of hen's egg albumin method [52a,b] at the 
concentration (31.25-1000 µg/mL) with standard aceclof nac drug. The outcome of anti-
inflammatory screening of the title compounds are summarized in Table 4. The percentage 
inhibition of all the synthesized compounds showed higher activity against the denaturation of 
protein. Among the compounds, [Ni(HL)2].H2O, [Cu(HL)2] and [Zn(HL)2]  exhibited an 
excellent inhibition of heat induced protein denatur ion 80.6%, 55.3% and 45.3% respectively 
and these compounds are more active compared to standard aceclofenac drug (43.2%). All the 
metal complexes showed good inhibitory anti-inflammatory activity than the free ligand against 
















In the present work, Co(II), Ni(II), Cu(II) and Zn(II) complexes of a new ligand, (E)-2-
amino-N'-(1-(2-hydroxy-6-methyl-4-oxo-4H-pyran-3-yl)ethylidene) benzohydrazide were 
designed and synthesized in good yield. Analytical and spectroscopic data for the metal 
complexes indicate a 1:1 (M: L) stoichiometry for [Cu(L)(H2O)] adopting a square planar 
geometry and 1:2 for the [Co(HL)2], [Ni(HL) 2].H2O, [Cu(HL)2] and [Zn(HL)2] adopting an 
octahedral geometry around the metal ion. The organic motif, H2L coordinated in monoanionic 
i.e. coordinating through oxygen of –OH group (pyranone ri g) via deprotonation in [Co(HL)2], 
[Ni(HL) 2].H2O, [Cu(HL)2], [Zn(HL)2] and in dianionic form i.e. deprotonation after enolisation 
of amide carbonyl & deprotonation of –OH group (pyranone ring) in [Cu(L)(H2O)]. Thus, the 
ligand acts in mono as well as doubly deprotonated manner. The tentative structures for metal 
complexes are depicted in figure 6. All interactions i  crystal structures of H2L, [Ni(HL) 2].H2O 
and [Cu(L)DMF] have also been studied by Hirshfeld surface analysis. H2L and its metal 
complexes have also been screened for their in vivo and in vitro anti-inflammatory activities. The 
results showed that activity of ligand has enhanced on complexation. The increase in activity of 
the metal complexes is probably due to the greater lipophilic nature of the complexes.  Among 
the complexes tested, [Cu(HL)2] has shown highest activity. The difference in activity among the 
tested compounds may be attributed to the electrosta ic nature of ligand and central metal ion. 
 
5. Significance and justification 
The present research reports in vivo and in vitro anti-inflammatory activity of late first row 
transition metal complexes of novel ligand. The results showed that activity of ligand has 
enhanced on complexation.  The results of the present tudy are quite inspiring and warrant 


















Appendix A. Supplementary data 
Crystallographic data for the structural analysis have been deposited with the Cambridge 
Crystallographic Data Centre, CCDC reference number: 1534307 (H2L), 1534306 
([Ni(HL) 2].H2O) and 1534309 ([Cu(L)DMF]). Copies of this information may be obtained free 
of the charge from the Director, CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK (Fax: +44-
1223-336033; E-mail: deposit@ ccdc.cam.ac.uk or http://www.ccd.cam.ac.uk). 
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Reagents and Conditions : (i) NH2.NH2.H2O, MeOH, Reflux (8-9 h) 





















































































Fig. 4b. Hirshfeld surfaces mapped with dnorm and 2D fingerprint plot of [Ni(HL)2].H2O 































Fig. 4c. Hirshfeld surfaces mapped with dnorm and 2D fingerprint plot of [Cu(L)(DMF)] depicting 
all intermolecular contributions. 
 
Fig. 4d. Distribution of individual intermolecular interactions on the basis of Hirshfeld surface 
















Fig. 5a. Anti-inflammatory activity of H2L and its metal complexes at different time intervals 
(0.5 to 5 h) with 5 mg/kg dose.  
 
Fig. 5b. Anti-inflammatory activity of H2L and its metal complexes at different time intervals 


























































Fig. 6. Tentatively proposed structures of [Co(HL)2], [Cu(HL)2], [Zn(HL)2]  and [Cu(L)(H2O)]. 
 
 
Table 1. Selected bond lengths and angles of  H2L ,[Ni(HL) 2].H2O  and [Cu(L)DMF]. 
 
 H2L [Ni(HL) 2].H2O   [Cu(L)DMF] 
Bond angles (°) 
C7-N2-N3  113.9(10) 115.9(3) 110.4(12)  
O1-C7-N2 121.5(11) 121.2(3) 124.5(14) 
C8-N3-N2 124.1(10) 119.9(2) 116.7(13) 
O2-C11-C10  123.2(11) 125.5(3) 126.1(14) 
Bond lengths (Å) 
N1-C1 1.359(17) 1.361(7) 1.382(2) 
O1-C7 1.231(15) 1.240(4) 1.299(19) 
N2-C7 1.378(15) 1.344(4) 1.318(2) 
N2-N3 1.388(14) 1.396(3) 1.396(17) 
O2-C11 1.260(15) 1.276(4) 1.281(19) 

















Table 2. Hydrogen bonding (Å, °) in H2L, [Ni(HL) 2].H2O  and [Cu(L)DMF]. 
 
D-H···Aa  interactions d(D···A)/Å D-H···A/° 
H2L 
N1A-H1AA···O2C#1 2.870(14) 170.0(17) 
N1A-H1AB···O1A 2.712(15) 132.6(15) 
N2A-H2A···O4C 2.764(13) 166.1(15) 
N3A-H3AB···O2A 2.481(13) 143.6(17) 
N1B-H1BA···O1A#2 3.349(16) 152.2(17) 
N1B-H1BA···O2A#2 2.922(14) 123.3(16) 
N1B-H1BB···O1B 2.743(16) 131.9(14) 
N2B-H2B···O4A#3 2.916(13) 175.3(16) 
N3B-H3BB···O2B 2.540(13) 136.6(16) 
N1C-H1CA···O2B#4 2.935(15) 171.6(18) 
N1C-H1CB···O1C 2.733(17) 130.3(17) 
N1C-H1CB···O1W#4 3.127(10) 147.1(18) 
N2C-H2C···O4B  2.804(14) 171.6(16) 
N3C-H3CB···O2C 2.515(14) 141.8(16) 
[Ni(HL) 2].H2O   
N1-H1A···O4#5 3.312(5) 149(6) 
N1-H1B···Ow 3.207(8) 167(5) 
N2-H2A···O4#6 2.978(4) 162(4) 
Ow-H5A···O2#7 2.853(4) 142(11) 
[Cu(L)DMF] 
N1-H1A···N2 2.691(19) 136.0(2) 
N1-H1B···O4#8 2.997(18) 173.0(2) 
D: donor; A: acceptor 
aSymmetry codes: #1: +X,+Y,-1+Z ;  #2: 1/2-X,-1/2+Y,1/2-Z;   #3: 1/2-X,-1/2+Y,3/2-Z; #4: 
















Table 3. In vivo anti-inflammatory activity of H2L and its metal complexes. 
 
Treatment 0.5 h 0.5 h 3 h 5 h 
 Paw volume (ml) % EI Paw volume (ml) % EI Paw volume (ml) % EI Paw volume (ml) % EI 







97.2 0.0300±0.0267***  
 
97.26 0.1083±0.0401***  
 




-1) 0.2839±0.0264***  
 
90.02 0.1686±0.0184***  
 
65.26 0.7464±0.0173**  
 




-1) 0.2481±0.0326***  
 
87.20 0.1745±0.0326***  
 
69.25 0.8453±0.0275**  
 














































-1) 0.2937±0.0264***  
 
87.23 0.1546±0.0153***  
 
76.02 0.7455±0.0245**  
 




-1) 0.2367±0.0232***  89.55 0.1014±0.0176***  79.02 0.5234±0.0257**  36.52 0.5321±0.0165***  89.25 
[Zn(HL)2] (5mg kg
-1) 0.4673±0.0265*** 85.03 0.2675±0.0164*** 76.25 0.5743±0.0143***  64.59 0.5143±0.0164*** 96.52 
[Zn(HL)2] (10mgkg
-1) 0.3856±0.0156*** 86.66 0.1675±0.0168** 80.25 0.5325±0.0156*** 62.82 0.2532±0.0153*** 92.52 
[Cu(L)(H2O)] (5mg kg
-1) 0.2464±0.0267***  95.21 0.2015±0.0273**  
 
81.25 0.7833±0.0174**  
 






93.21 0.1945±0.0183***  
 
85.26 0.7845±0.0126**  
 




All values are expressed as mean SEM, ANOVA followed by Dunnett’s test 



















Table 4. In-vitro anti-inflammatory activity of H2L and its metal complexes. 
Entry Metal % Inhibition of egg albumin in 250 g/mL 
Aceclofenac — 43.2 
H2L — 33.9 
[Co(HL)2] Co 34.8 
[Ni(HL) 2].H2O Ni 80.6 
[Cu(HL)2] Cu 55.3 
[Zn(HL)2] Zn 45.3 
[Cu(L)(H2O)] Cu 38.4 
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• Ligand exhibited monobasic as well as dibasic nature during complexation. 
• Metal complexes adopt square planar and octahedral geometry. 
• Hirshfeld surface analysis has been carried out. 
• Anti-inflammatory activity of ligand enhanced on complexation. 
• Copper complex has shown highest activity among the tested compounds. 
 
